<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02641288</url>
  </required_header>
  <id_info>
    <org_study_id>HURJC15-77</org_study_id>
    <nct_id>NCT02641288</nct_id>
  </id_info>
  <brief_title>Intraperitoneal Ropivacaine Irrigation in Bariatric Surgery</brief_title>
  <official_title>Intraperitoneal Ropivacaine Irrigation in Patients Undergoing Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Universitario Elche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General Universitario Elche</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective randomized clinical trial of all the patients undergoing laparoscopic sleeve
      gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (LRYGB) will be performed.
      Patients will be randomized in 2 groups: those patients undergoing intraperitoneal
      ropivacaine irrigation (Experimental Group - EG) and those undergoing intraperitoneal
      irrigation with normal saline (Control Group - CG).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective randomized clinical trial of all the patients undergoing laparoscopic sleeve
      gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (LRYGB) will be performed.
      Patients will be randomized in 2 groups: those patients undergoing intraperitoneal
      ropivacaine irrigation 300mg in 200 ml(Experimental Group - EG) and those undergoing
      intraperitoneal irrigation with normal saline 200ml (Control Group - CG).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Postoperative pain will be evaluated by a blinded nurse 24 hours after surgery. Pain will be quantified using a visual analogic scale (VAS), ranging from 0(absence of pain) to 10 (unbearable pain).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Ropivacaine irrigation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using a standard irrigation device, 300 mg total of ropivacaine in 200ml normal saline will be instilled into the abdomen after surgical dissection, just before abdominal wall closure. Under direct visualization, the solution is delivered over the oesophageal hiatus, over both anastomoses and in both subdiaphragmatic spaces.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline irrigation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Using a standard irrigation device, 200ml normal saline will be instilled into the abdomen after surgical dissection, just before abdominal wall closure. Under direct visualization, the solution is delivered over the oesophageal hiatus, over both anastomoses and in both subdiaphragmatic spaces.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine irrigation</intervention_name>
    <description>Using a standard irrigation device (no specific device is being used), 300 mg total of ropivacaine in 200ml normal saline will be instilled into the abdomen after surgical dissection, just before abdominal wall closure. Under direct visualization, the solution is delivered over the oesophageal hiatus, over both anastomoses and in both subdiaphragmatic spaces.</description>
    <arm_group_label>Ropivacaine irrigation</arm_group_label>
    <other_name>Intraperitoneal Ropivacaine irrigation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline irrigation</intervention_name>
    <description>Using a standard irrigation device (no specific device is being used), 200ml normal saline will be instilled into the abdomen after surgical dissection, just before abdominal wall closure.</description>
    <arm_group_label>Normal saline irrigation</arm_group_label>
    <other_name>Intraperitoneal Normal saline irrigation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index (BMI) &gt;40 Kg/m2

          -  BMI &gt; 35 Kg/m2 with the presence of comorbidities associated to obesity.

        Exclusion Criteria:

          -  patients undergoing other bariatric techniques or revisional surgery

          -  allergy to local anesthetics

          -  severe underlying cardiovascular diseases

          -  chronic renal failure

          -  hepatic dysfunction

          -  previous foregut surgery

          -  patients with any contraindication for bariatric surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan Gonzalez, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital General Elche</affiliation>
  </overall_official>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2015</study_first_submitted>
  <study_first_submitted_qc>December 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2015</study_first_posted>
  <last_update_submitted>December 22, 2015</last_update_submitted>
  <last_update_submitted_qc>December 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario Elche</investigator_affiliation>
    <investigator_full_name>Jaime Ruiz-Tovar, MD, PhD</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

